Christopher Simon, - Net Worth and Insider Trading

Christopher Simon, Net Worth

The estimated net worth of Christopher Simon, is at least $18 Million dollars as of 2024-04-25. Christopher Simon, is the President & CEO of Haemonetics Corp and owns about 213,724 shares of Haemonetics Corp (HAE) stock worth over $18 Million. Details can be seen in Christopher Simon,'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Simon, has not made any transactions after 2022-06-13 and currently still holds the listed stock(s).

Transaction Summary of Christopher Simon,

To

Christopher Simon, Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Simon, owns 1 companies in total, including Haemonetics Corp (HAE) .

Click here to see the complete history of Christopher Simon,’s form 4 insider trades.

Insider Ownership Summary of Christopher Simon,

Ticker Comapny Transaction Date Type of Owner
HAE Haemonetics Corp 2022-06-13 director & President & CEO

Christopher Simon, Latest Holdings Summary

Christopher Simon, currently owns a total of 1 stock. Christopher Simon, owns 213,724 shares of Haemonetics Corp (HAE) as of June 13, 2022, with a value of $18 Million.

Latest Holdings of Christopher Simon,

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HAE Haemonetics Corp 2022-06-13 213,724 86.22 18,427,283

Holding Weightings of Christopher Simon,


Christopher Simon, Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Simon, has made a total of 15 transactions in Haemonetics Corp (HAE) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Haemonetics Corp is the sale of 1,148 shares on June 13, 2022, which brought Christopher Simon, around $71,865.

Insider Trading History of Christopher Simon,

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Simon, Trading Performance

GuruFocus tracks the stock performance after each of Christopher Simon,'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Simon, is -1.64%. GuruFocus also compares Christopher Simon,'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Simon, within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christopher Simon,'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christopher Simon,

Average Return

18.29%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.56 -1.64 18.72 18.29 66.77 51.82
Relative Return to S&P 500(%) 7.83 2.01 12.57 3.85 52.19 41.15

Christopher Simon, Ownership Network

Ownership Network List of Christopher Simon,

No Data

Ownership Network Relation of Christopher Simon,


Christopher Simon, Owned Company Details

What does Haemonetics Corp do?

Who are the key executives at Haemonetics Corp?

Christopher Simon, is the director & President & CEO of Haemonetics Corp. Other key executives at Haemonetics Corp include President & Global Hospital Stewart W Strong , EVP & Chief Technology Officer Anila Lingamneni , and EVP & Global Manufacturing Josep Llorens .

Haemonetics Corp (HAE) Insider Trades Summary

Over the past 18 months, Christopher Simon, made no insider transaction in Haemonetics Corp (HAE). Other recent insider transactions involving Haemonetics Corp (HAE) include a net sale of 7,319 shares made by Josep Llorens , a net sale of 4,609 shares made by Anila Lingamneni , and a net sale of 2,766 shares made by Stewart W Strong .

In summary, during the past 3 months, insiders sold 0 shares of Haemonetics Corp (HAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 24,909 shares of Haemonetics Corp (HAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 24,909 shares.

Haemonetics Corp (HAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Haemonetics Corp Insider Transactions

No Available Data

Christopher Simon, Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Simon,. You might contact Christopher Simon, via mailing address: Haemonetics Corporation, 400 Wood Road, Braintree Ma 02184.

Discussions on Christopher Simon,

No discussions yet.